-
J&J’s Janssen and BIDMC team up on Covid-19 vaccine
pharmaceutical-technology
March 17, 2020
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has partnered with the Beth Israel Deaconess Medical Center (BIDMC) to advance Covid-19 vaccine development.
-
CureVac works on mRNA vaccine for coronavirus
pharmaceutical-technology
March 17, 2020
German biopharmaceutical company CureVac is working on the development of an mRNA-based vaccine to protect against Covid-19 coronavirus infection.
-
BioNTech Reports Progress on COVID-19 Vaccine Program
contractpharma
March 17, 2020
Partnered with Fosun in China and Pfizer elsewhere; anticipates start of clinical testing for vaccine in late April 2020.
-
Medicago produces viable Covid-19 vaccine candidate
pharmaceutical-technology
March 16, 2020
Biopharmaceutical firm Medicago has produced a Virus-Like Particle (VLP) of the novel coronavirus, marking the first step in Covid-19 vaccine development.
-
Inovio secures funds for delivery device of Covid-19 vaccine
pharmaceutical-technology
March 16, 2020
Inovio Pharmaceuticals has received a $5m grant from the Bill & Melinda Gates Foundation to support the testing and scale-up of a smart delivery device for Covid-19 vaccine, INO-4800.
-
Special report highlights potential therapeutic agents, vaccines for COVID-19
worldpharmanews
March 16, 2020
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic.
-
India needs to get into vaccine production in a big way: Kiran Mazumdar-Shaw
expresspharma
March 13, 2020
India should step up research on communicable diseases and get into vaccine production in a big way, says biotechnology industry veteran Kiran Mazumdar-Shaw in the backdrop of the coronavirus outbreak globally.
-
Novavax secures CEPI funding for Covid-19 vaccine
pharmaceutical-technology
March 12, 2020
Novavax has received initial funding of $4m from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of a Covid-19 vaccine.
-
Integral Molecular to work on coronavirus vaccine research
pharmaceutical-technology
March 12, 2020
US-based biotechnology company Integral Molecular will leverage its technology platforms to identify Covid-19 vaccines and therapeutics.
-
Serum Institute plans COVID-19 vaccine by 2022
expresspharma
March 12, 2020
States the need for fast-tracking of regulatory clearances for the vaccine.